ウイルス学標本収集市場

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2021年12月

ウイルス学標本収集市場: 製品(ウイルス輸送メディア、綿棒、採血キット、検体採取チューブ)、サンプルタイプ(血液、子宮頸部、鼻、鼻咽頭、喉、口腔)、地域別 – 2026年までの世界予測

Virology Specimen Collection Market by Product (Viral Transport Media, Swabs, Blood Collection Kits, Specimen Collection Tubes), Sample Type (Blood, Cervical, Nasal, Nasopharyngeal, Throat, Oral), Region-Global Forecast to 2026

ページ数 78
図表数 42
種別 英文調査報告書
価格

レポート目次    見積ご依頼・お問合せ    ご購入案内

無料サンプル

The global virology specimen collectionmarket is projected to reach USD 5.4billion by 2026 from USD 5.6billion in 2021, at a CAGR of -0.6% during the forecast period. Market growth is driven by factors such as the growth in rising number of blood donations and rising prevalence of viral diseases and emergence of newer pathogens. On the other hand, high cost of technologies and collection kits and usage of flow sensitivity screening are the major factors hampering the growth of this market.
“The viral transport media segment accounted for the highest growth rate in thevirology specimen collectionmarket, by product, during the forecast period”
Thevirology specimen collectionmarket is segmented into test blood collection kits specimen collection tubes, swabs and viral transport media based on product. In 2020, the viral transport mediasegment accounted for the highest growth rate in the virology specimen collectionmarket. Rising number of blood donations is the major factor contributing to the growth of this segment.
“The blood samples segmentaccounted for the highest growth rate in the virology specimen collectionmarket, by sample type, during the forecast period”
The virology specimen collectionmarket is segmented into blood, nasopharyngeal, nasal, throat, cervical and oral based on sample type. In 2020, the blood sample segment accounted for the highest growth rate in the virology specimen collectionmarket.Rising prevalence of viral diseases and emergence of newer pathogens is themajor factor contributing to the growth of this segment.
“Asia Pacific: The fastest-growing regionin virology specimen collectionmarket”
The global virology specimen collectionmarket is segmented into North America, Europe, the Asia Pacific and Rest of the World. The Asia Pacific region is projected to register the highest CAGR during the forecast period.Factors such as the rising number of blood donationsare driving the growth of the virology specimen collectionmarket in this region.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1 – 40%, Tier 2 – 30%,and Tier 3 -30%
• By Designation: C-level – 27%, D-level – 18%, and Others – 55%
• By Region: North America -51%, Europe – 21%, Asia Pacific – 18% and Rest of the World – 10%
Lists of Companies Profiled in the Report:

• Becton, Dickinson and Company (US)
• Quidel Corporation (US)
• Thermo Fisher Scientific, Inc. (US)
• Trinity Biotech (Ireland)
• Titan Biotech, Ltd. (India)
• Diasorin SA (Italy)
• Vircell S.L. (Spain)
• Copan Italia S.p.A. (Italy)
• Puritan Medical Products, Co. (Guilford, ME)
• Hardy Diagnostics (US).
Research Coverage:
This report provides a detailed picture of the global virology specimen collectionmarket. It aims at estimating the size and future growth potential of the market across different segments, such as product,sample type and region. The report also includes an in-depth competitive analysis ofthe key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall virology specimen collectionmarket and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.


目次

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 13
1.2.2 MARKETS COVERED 14
FIGURE 1 VIROLOGY SPECIMEN COLLECTION MARKET SEGMENTATION 14
1.2.3 YEARS CONSIDERED FOR THE STUDY 14
1.3 CURRENCY 15
1.4 LIMITATIONS 15
1.5 STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 RESEARCH DATA 16
2.2 RESEARCH APPROACH 16
FIGURE 2 VIROLOGY SPECIMEN COLLECTION MARKET: RESEARCH DESIGN 16
2.2.1 SECONDARY DATA 17
2.2.1.1 Key data from secondary sources 17
2.2.2 PRIMARY DATA 18
2.2.2.1 Key data from primary sources 18
2.2.2.2 Key industry insights 19
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 19
2.3 MARKET SIZE ESTIMATION 20
2.3.1 BOTTOM-UP APPROACH 20
FIGURE 4 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 20
2.3.2 TOP-DOWN APPROACH 20
FIGURE 5 VIROLOGY SPECIMEN COLLECTION MARKET: TOP-DOWN APPROACH 21
2.4 ASSUMPTIONS FOR THE STUDY 21
2.5 GROWTH RATE ASSUMPTIONS 22
2.6 LIMITATIONS 22
2.7 RISK ASSESSMENT 22
2.8 COVID-19 HEALTH ASSESSMENT 22
2.9 COVID-19 ECONOMIC ASSESSMENT 23
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 23
FIGURE 6 CRITERIA IMPACTING THE GLOBAL ECONOMY 23
FIGURE 7 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 24
2.11 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE VIROLOGY SPECIMEN
COLLECTION MARKET 25
3 MARKET OVERVIEW 26
3.1 INTRODUCTION 26
3.2 MARKET DYNAMICS 26
FIGURE 8 VIROLOGY SPECIMEN COLLECTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
3.2.1 DRIVERS 27
3.2.1.1 Rising prevalence of viral diseases and emergence of
newer pathogens 27
3.2.1.2 Rising number of blood donations 27
3.2.2 RESTRAINTS 28
3.2.2.1 Need for alternative technologies 28
3.2.3 OPPORTUNITIES 28
3.2.3.1 Technological advancements 28
3.2.3.2 Lucrative opportunities in emerging economies 29
3.2.4 CHALLENGES 29
3.2.4.1 High cost of technologies and collection kits 29
3.2.4.2 Usage of low-sensitivity screening 30
3.3 IMPACT OF COVID-19 ON THE VIROLOGY SPECIMEN COLLECTION MARKET 30
3.4 PESSIMISTIC, OPTIMISTIC, AND REALISTIC SCENARIOS 31
3.4.1 VIROLOGY SPECIMEN COLLECTION MARKET 31
FIGURE 9 PESSIMISTIC SCENARIO 31
FIGURE 10 OPTIMISTIC SCENARIO 32
FIGURE 11 REALISTIC SCENARIO 32
3.5 PRICING ANALYSIS 33
TABLE 1 PRICE OF VIROLOGY SPECIMEN COLLECTION PRODUCTS (2021) 33
3.6 PATENT ANALYSIS 33
3.6.1 PATENT ANALYSIS OF VIRAL TRANSPORT MEDIA 33
3.6.2 PATENT ANALYSIS OF BLOOD COLLECTION KITS 34
3.7 TRADE ANALYSIS 34
3.7.1 TRADE ANALYSIS FOR DIAGNOSTIC REAGENTS 34
TABLE 2 IMPORT DATA FOR PREPARED CULTURE MEDIA FOR THE DEVELOPMENT OR MAINTENANCE OF MICRO-ORGANISMS INCL. VIRUSES AND THE LIKE OR OF PLANT, HUMAN OR ANIMAL CELLS, BY COUNTRY, 2016–2020 (USD MILLION) 34
TABLE 3 EXPORT DATA FOR PREPARED CULTURE MEDIA FOR THE DEVELOPMENT OR MAINTENANCE OF MICRO-ORGANISMS INCL. VIRUSES AND THE LIKE OR OF PLANT, HUMAN OR ANIMAL CELLS, BY COUNTRY, 2016–2020 (USD MILLION) 35
3.8 VALUE CHAIN ANALYSIS 35
FIGURE 12 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE 35
3.9 SUPPLY CHAIN ANALYSIS 36
FIGURE 13 VIROLOGY SPECIMEN COLLECTION MARKET: SUPPLY CHAIN ANALYSIS 37
3.10 ECOSYSTEM ANALYSIS OF THE VIROLOGY SPECIMEN COLLECTION MARKET 37
FIGURE 14 VIROLOGY SPECIMEN COLLECTION MARKET: ECOSYSTEM ANALYSIS 37
3.10.1 ROLE IN ECOSYSTEM 37
3.11 PORTER’S FIVE FORCES ANALYSIS 38
TABLE 4 VIROLOGY SPECIMEN COLLECTION MARKET: PORTER’S FIVE
FORCES ANALYSIS 38
3.11.1 THREAT OF NEW ENTRANTS 38
3.11.2 THREAT OF SUBSTITUTES 38
3.11.3 BARGAINING POWER OF BUYERS 38
3.11.4 BARGAINING POWER OF SUPPLIERS 38
3.11.5 DEGREE OF COMPETITION 39
3.12 REGULATORY LANDSCAPE 39
3.12.1 NORTH AMERICA 39
3.12.1.1 US 39
3.12.1.2 Canada 39
3.12.2 EUROPE 39
3.12.3 ASIA PACIFIC 40
3.12.3.1 Japan 40
3.12.3.2 India 40
3.12.4 LATIN AMERICA 40
3.12.4.1 Brazil 40
3.12.4.2 Mexico 40
3.12.5 MIDDLE EAST 41
3.13 CASE STUDY ANALYSIS 41
3.13.1 CASE STUDY 1 41
3.14 TECHNOLOGY ANALYSIS 41
3.15 TRENDS/DISRUPTIONS IMPACTING THE BUSINESS OF CUSTOMERS 43
3.15.1 REVENUE SOURCES ARE SHIFTING TOWARD MORE TECHNOLOGY-BASED SOLUTIONS DUE TO THE COVID-19 PANDEMIC 43
3.15.2 REVENUE SHIFT FOR THE VIROLOGY SPECIMEN COLLECTION MARKET 43
4 VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE 44
4.1 INTRODUCTION 45
TABLE 5 VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE,
2019–2026 (USD MILLION) 45
4.2 VIRAL TRANSPORT MEDIA 45
4.2.1 REPEAT PURCHASE OF VIRAL TRANSPORT MEDIA TO DRIVE MARKET
GROWTH IN THE COMING YEARS 45
TABLE 6 VIROLOGY SPECIMEN COLLECTION MARKET FOR VIRAL TRANSPORT
MEDIA, BY REGION, 2019–2026 (USD MILLION) 46
4.3 SPECIMEN COLLECTION TUBES 46
4.3.1 SURGE IN PATIENT POPULATION TO DRIVE SEGMENT GROWTH 46
TABLE 7 VIROLOGY SPECIMEN COLLECTION MARKET FOR SPECIMEN COLLECTION TUBES, BY REGION, 2019–2026 (USD MILLION) 46
4.4 SWABS 47
4.4.1 INCREASING INCIDENCE OF VIRAL DISEASES TO PROPEL MARKET GROWTH 47
TABLE 8 VIROLOGY SPECIMEN COLLECTION MARKET FOR SWABS, BY REGION,
2019–2026 (USD MILLION) 47
4.5 BLOOD COLLECTION KITS 48
4.5.1 GROWING PRESSURE ON CLINICAL LABORATORIES TO DRIVE THE
MARKET GROWTH 48
TABLE 9 VIROLOGY SPECIMEN COLLECTION MARKET FOR BLOOD COLLECTION
KITS, BY REGION, 2019–2026 (USD MILLION) 48
5 VIROLOGY SPECIMEN COLLECTION MARKET, BY SAMPLE 49
5.1 INTRODUCTION 50
TABLE 10 VIROLOGY SPECIMEN COLLECTION MARKET, BY SAMPLE,
2019–2026 (USD MILLION) 50
5.2 BLOOD SAMPLES 50
5.2.1 RISING NUMBER OF LEUKEMIA AND LYMPHOMA CASES WILL SUPPORT
THE MARKET GROWTH 50
TABLE 11 VIROLOGY SPECIMEN COLLECTION MARKET FOR BLOOD SAMPLES,
BY REGION, 2019–2026 (USD MILLION) 51
5.3 CERVICAL SAMPLES 51
5.3.1 INCREASING INCIDENCE OF HPV WILL DRIVE THE GROWTH OF THIS SEGMENT 51
TABLE 12 VIROLOGY SPECIMEN COLLECTION MARKET FOR CERVICAL SAMPLES,
BY REGION, 2019–2026 (USD MILLION) 52
5.4 NASAL SAMPLES 52
5.4.1 RISING PREVALENCE OF RESPIRATORY DISORDERS TO SUPPORT THE MARKET GROWTH 52
TABLE 13 VIROLOGY SPECIMEN COLLECTION MARKET FOR NASAL SAMPLES,
BY REGION, 2019–2026 (USD MILLION) 52
5.5 NASOPHARYNGEAL SAMPLES 53
5.5.1 INCREASE IN NUMBER OF RT-PCR TESTS WILL DRIVE THE GROWTH
OF THIS SEGMENT 53
TABLE 14 VIROLOGY SPECIMEN COLLECTION MARKET FOR NASOPHARYNGEAL SAMPLES, BY REGION, 2019–2026 (USD MILLION) 53
5.6 THROAT SAMPLES 53
5.6.1 INCREASING PREVALENCE OF VIRAL DISEASES TO DRIVE THE
SEGMENT GROWTH 53
TABLE 15 VIROLOGY SPECIMEN COLLECTION MARKET FOR THROAT SAMPLES,
BY REGION, 2019–2026 (USD MILLION) 54
5.7 ORAL SAMPLES 54
5.7.1 QUICK DIAGNOSTIC RESULTS THROUGH ORAL SWABS TO DRIVE
THE GROWTH OF THIS MARKET 54
TABLE 16 VIROLOGY SPECIMEN COLLECTION MARKET FOR ORAL SAMPLES,
BY REGION, 2019–2026 (USD MILLION) 54
5.8 OTHER SAMPLES 55
TABLE 17 VIROLOGY SPECIMEN COLLECTION MARKET FOR OTHER SAMPLES,
BY REGION, 2019–2026 (USD MILLION) 55

6 VIROLOGY SPECIMEN COLLECTION MARKET, BY REGION 56
6.1 INTRODUCTION 57
TABLE 18 VIROLOGY SPECIMEN COLLECTION MARKET, BY REGION,
2019–2026 (USD MILLION) 57
6.2 NORTH AMERICA 57
6.2.1 RISING PREVALENCE OF HIV IN THE REGION WILL SUPPORT THE MARKET GROWTH 57
FIGURE 15 NORTH AMERICA: VIROLOGY SPECIMEN COLLECTION MARKET SNAPSHOT 58
TABLE 19 NORTH AMERICA: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2019–2026 (USD MILLION) 59
TABLE 20 NORTH AMERICA: VIROLOGY SPECIMEN COLLECTION MARKET, BY SAMPLE, 2019–2026 (USD MILLION) 59
6.3 EUROPE 59
6.3.1 RISING INCIDENCE OF HUMAN PAPILLOMAVIRUS TO SUPPORT GROWTH 59
TABLE 21 EUROPE: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2019–2026 (USD MILLION) 60
TABLE 22 EUROPE: VIROLOGY SPECIMEN COLLECTION MARKET, BY SAMPLE,
2019–2026 (USD MILLION) 60
6.4 ASIA PACIFIC 61
6.4.1 APAC MARKET IS MAINLY DRIVEN BY LARGE-SCALE COVID TESTING ACTIVITY 61
FIGURE 16 ASIA PACIFIC: VIROLOGY SPECIMEN COLLECTION MARKET SNAPSHOT 62
TABLE 23 ASIA PACIFIC: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2019–2026 (USD MILLION) 62
TABLE 24 ASIA PACIFIC: VIROLOGY SPECIMEN COLLECTION MARKET, BY SAMPLE, 2019–2026 (USD MILLION) 63
6.5 REST OF THE WORLD 63
TABLE 25 REST OF THE WORLD: VIROLOGY SPECIMEN COLLECTION MARKET,
BY PRODUCT TYPE, 2019–2026 (USD MILLION) 64
TABLE 26 REST OF THE WORLD: VIROLOGY SPECIMEN COLLECTION MARKET,
BY SAMPLE, 2019–2026 (USD MILLION) 64
7 COMPANY PROFILES 65
7.1 KEY PLAYERS 65
7.1.1 BECTON, DICKINSON AND COMPANY 65
7.1.2 QUIDEL CORPORATION 66
7.1.3 THERMO FISHER SCIENTIFIC, INC. 67
7.1.4 TRINITY BIOTECH 68
7.1.5 TITAN BIOTECH LTD. 69
7.1.6 DIASORIN SA 69
7.1.7 VIRCELL S.L. 70
7.1.8 COPAN ITALIA S.P.A 70
7.1.9 PURITAN MEDICAL PRODUCTS CO. 71
7.1.10 HARDY DIAGNOSTICS 72

8 APPENDIX 73
8.1 INSIGHTS FROM INDUSTRY EXPERTS 73
8.2 DISCUSSION GUIDE 74
8.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 76
8.4 AVAILABLE CUSTOMIZATIONS 78
8.5 AUTHOR DETAILS 79


    お問合せ/ご依頼内容

    • レポートのタイトルは自動で入ります。
    • ※のある項目は必須項目です。

    お名前(

    会社名(

    部署名

    メールアドレス(

    電話番号

    当ウェブサイトを知った経由を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com